This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Celgene Corporation, Signal Pharmaceuticals, Inc.. Active years: 2001-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Raleigh, NC (US) (2001)
- Roseland, NJ (US) (2018 - 2022)
Company Filing History:

Years Active: 2001-2022
Title: Paul F. Fernandez: Innovator in Pharmaceutical Compositions
Introduction
Paul F. Fernandez is a notable inventor based in Roseland, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work primarily focuses on solid forms of various chemical compounds and their applications in medicine.
Latest Patents
Among his latest patents are innovative formulations such as solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide. These patents detail pharmaceutical compositions and methods of use for these solid forms. Another significant patent involves solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide, which also includes formulations and methods of use.
Career Highlights
Throughout his career, Paul has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Signal Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas.
Collaborations
Paul has collaborated with several professionals in his field, including Carson Fernandez and Antonio Christian Ferretti. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Paul F. Fernandez is a distinguished inventor whose work in pharmaceutical compositions has led to multiple patents and significant advancements in the field. His contributions continue to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile